Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Provided By GlobeNewswire
Last update: Nov 18, 2024
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8
IM8 launch marks a bold entry into the $187 billion global consumer health market
Read more at globenewswire.comNASDAQ:PRE (8/29/2025, 8:00:01 PM)
7.615
+0.21 (+2.91%)
Find more stocks in the Stock Screener
